Page last updated: 2024-10-28

hypericin and Adenocarcinoma of Lung

hypericin has been researched along with Adenocarcinoma of Lung in 1 studies

Adenocarcinoma of Lung: A carcinoma originating in the lung and the most common lung cancer type in never-smokers. Malignant cells exhibit distinct features such as glandular epithelial, or tubular morphology. Mutations in KRAS, EGFR, BRAF, and ERBB2 genes are associated with this cancer.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gyurászová, K1
Mikeš, J1
Halaburková, A1
Jendželovský, R1
Fedoročko, P1

Other Studies

1 other study available for hypericin and Adenocarcinoma of Lung

ArticleYear
YM155, a small molecule inhibitor of survivin expression, sensitizes cancer cells to hypericin-mediated photodynamic therapy.
    Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology, 2016, 06-08, Volume: 15, Issue:6

    Topics: Adenocarcinoma; Adenocarcinoma of Lung; Anthracenes; Antineoplastic Agents; Autophagy; Caspase 3; Ce

2016